SkinBioTherapeutics (GB:SBTX) has released an update.
Stay Ahead of the Market:
- Discover outperforming stocks and invest smarter with Top Smart Score Stocks
- Filter, analyze, and streamline your search for investment opportunities using Tipranks' Stock Screener
SkinBioTherapeutics, a UK-based life science company specializing in skin health, announced a brief delay in releasing its fiscal year results due to logistical issues with auditor sign-off. The company is actively expanding its product line and market presence through strategic acquisitions and partnerships, including its innovative AxisBiotix-Ps™ supplement for psoriasis. This growth strategy could pique the interest of investors looking for opportunities in the skin care and health sectors.
For further insights into GB:SBTX stock, check out TipRanks’ Stock Analysis page.
